$PRAX

$267.59 +$0.20 (0.07%) Close

$PRAX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$PRAX Management Team

Mr. Dean Mitchell

Independent Chairman of the Board

Age 69

Compensation $389.0K USD

Sex Male

Mr. Marcio Souza

President

Chief Executive Officer

Director

Age 46

Compensation $13.43M USD

Sex Male

Mr. Timothy Kelly

Chief Financial Officer

Age 52

Compensation $4.045M USD

Sex Male

Mr. Alex Nemiroff

General Counsel

Corporate Secretary

Age 46

Compensation $3.918M USD

Sex Male

Ms. Megan Sniecinski

Chief Operating Officer

Age 45

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Dean Mitchell Independent Chairman of the Board	69	$389.0K USD	Male
Mr. Marcio Souza President Chief Executive Officer Director	46	$13.43M USD	Male
Mr. Timothy Kelly Chief Financial Officer	52	$4.045M USD	Male
Mr. Alex Nemiroff General Counsel Corporate Secretary	46	$3.918M USD	Male
Ms. Megan Sniecinski Chief Operating Officer	45	-	Female

Board of Directors

From the proxy statement filed Apr 30, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

4.8 years

from year joined

CEO also chairs the board

Dean Mitchell

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Gregory Norden	68	2019 7 years	Independent	None stated	Zoetis Inc. (NYSE: ZTS), Royalty Pharma plc (NASDAQ: RPRX)	$426,221
Marcio Souza CEO	47	2020 6 years	Not independent	None stated	None stated	Paid as CEO
William Young	81	2016 10 years	Independent	None stated	Autolus Therapeutics plc (NASDAQ: AUTL)	$418,721
Jill DeSimone	70	2022 4 years	Independent	None stated	Indegene Limited	$421,221
Dean Mitchell Board chair	70	2020 6 years	Independent	None stated	Theravance Biopharma, Inc. (NASDAQ: TBPH)	$445,221
Stuart Arbuckle	60	2026 0 years	Independent	None stated	Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)	Not stated
Jeffrey Chodakewitz, M.D.	70	2021 5 years	Independent	None stated	Adicet Bio, Inc. (NASDAQ: ACET), Schrödinger, Inc. (NASDAQ:SDGR)	$412,721
Merit Cudkowicz, M.D.	63	2021 5 years	Independent	None stated	None stated	$416,721
Jeffrey Kindler	70	2026 0 years	Independent	None stated	Perrigo Company plc (NYSE: PRGO), Precigen, Inc. (NASDAQ: PGEN), Terns Pharmaceuticals, Inc. (NASDAQ: TERN), Lupin Limited	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$PRAX Management Team

Mr. Dean Mitchell

Mr. Marcio Souza

Mr. Timothy Kelly

Mr. Alex Nemiroff

Ms. Megan Sniecinski

Board of Directors

Related-party transactions

No related-party transactions disclosed